A Resolution designating the month of May 2025 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This resolution designates May 2025 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania. The resolution aims to raise public awareness about ALS, a fatal neurodegenerative disease that affects motor neurons and leads to progressive muscle weakness and loss of function. It acknowledges the impact of the disease on patients and their families and recognizes ongoing research efforts.
Key provisions
- Designates May 2025 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.
- Recognizes Amyotrophic Lateral Sclerosis (ALS) as a fatal neurodegenerative disease.
- Details symptoms of ALS, including muscle weakness, difficulty swallowing, talking, and breathing.
- States that ALS does not affect mental capacity.
- Notes the typical age of diagnosis (55 years) and the average survival time (2-5 years).
- Highlights that ALS is more common in men.
- Indicates approximately 5,000 new cases are diagnosed annually.
- Acknowledges that there is currently no known cause, prevention, or cure for ALS.
Who is affected
- Individuals with Amyotrophic Lateral Sclerosis (ALS)
- Families and caregivers of individuals with ALS
- Pennsylvania residents
- Researchers studying ALS
- The general public
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 0795 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Christine Tartaglione
Daniel Laughlin
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours